• The Effects of Dry Needling on Knee Pain

    Official Title The Effects of Dry Needling on Patients with Knee Pain

    Purpose

    This study is testing the effectiveness of "dry needling" for pain management and on muscle strength and leg function for those with knee pain. Dry needling consists of small, monofilament needles that are administered directly into the tissue and manipulated to make the muscle relax for pain relief. This technique is used to treat dysfunctions in skeletal muscle and connective tissue to help diminish pain, reduce impairments of body structure and restore function.

    Could this study be right for you?

    Eligibility Criteria:
    --Ages 18-40
    --Referred for physical therapy
    --Presence of knee pain (for at least 3 months) around the knee cap (patella) during ascending/descending stairs, squatting, and/or running.

    Age Range

    18 and up
  • Ankle Function Study for Healthy Volunteers OR Those with Ankle Instability or Nerve Damage

    Official Title Assessing Reliability and Validity of an iPod App for Measuring Ankle Proprioception

    Purpose

    We will assess ankle function by measuring how well you detect ankle movement using an iPod app. This information will help us to determine the validity of using an iPod app as a clinical tool for measuring ankle function and perception of rotation

    The results of this study may inform us if the iPod app is an appropriate tool to use in the clinical setting as a more cost-effective, faster, and accessible tool when compared to the larger, more expensive Biodex machine.

    Could this study be right for you?

    Three groups (ages 18-80) are eligible for this study:

    --Group 1--Those who are 60-80 years old, without history of ankle instability or nerve damage to lower extremities.

    --Group 2--Those who are 18-60 years old and have a history of chronic ankle instability, recurrent ankle sprains. Have had at least 3 ankle sprains in the previous two (2) years, but none within 2 months of joining the study

    --Group 3--Those who are 18-60 years old and have been diagnosed with peripheral neuropathy that has been induced by chemotherapy. Further screening will be done by the study team.

    Age Range

    18 and up